Abstract
The effects on aggression in late adolescent male rats of acute administration (via intraperitoneal injection) of 10 or 20 mg/kg of the designer drug, benzylpiperazine (BZP), were assessed in comparison with 1 or 2 mg/kg of methamphetamine (MA). The two drugs are very similar in their behavioral and neurochemical effects. Aggression was measured with the resident/intruder test of aggression which involves recording eight forms of behavior in response to an intruder rat being placed in the resident drug-treated rat’s cage. Both drugs led to often dose- and specific drug-related changes in seven of the eight measures that were indicative of decreased (rather than increased) aggression which may have arisen from hyper-vigilance, increased activity or heightened fear/anxiety i.e., decreases in an aggressive posture, chasing and sniffing the intruder and self-grooming, accompanied by increases in adopting an alert position, rearing on hind legs and avoiding the intruder. It was concluded that acute treatment with neither MA nor BZP increased aggression. As revealed in earlier research with adult rats, both drugs proved to be remarkably similar in their overall behavioral effects.
Keywords: Anxiety, aggression, benzylpiperazine, methamphetamine, rat, resident/intruder test.
Current Psychopharmacology
Title:Acute Methamphetamine and Benzylpiperazine Decrease Aggression- Related Behavior in Late Adolescent Male Rats
Volume: 2
Author(s): Hamish N.L. Johnson and Robert N. Hughes
Affiliation:
Keywords: Anxiety, aggression, benzylpiperazine, methamphetamine, rat, resident/intruder test.
Abstract: The effects on aggression in late adolescent male rats of acute administration (via intraperitoneal injection) of 10 or 20 mg/kg of the designer drug, benzylpiperazine (BZP), were assessed in comparison with 1 or 2 mg/kg of methamphetamine (MA). The two drugs are very similar in their behavioral and neurochemical effects. Aggression was measured with the resident/intruder test of aggression which involves recording eight forms of behavior in response to an intruder rat being placed in the resident drug-treated rat’s cage. Both drugs led to often dose- and specific drug-related changes in seven of the eight measures that were indicative of decreased (rather than increased) aggression which may have arisen from hyper-vigilance, increased activity or heightened fear/anxiety i.e., decreases in an aggressive posture, chasing and sniffing the intruder and self-grooming, accompanied by increases in adopting an alert position, rearing on hind legs and avoiding the intruder. It was concluded that acute treatment with neither MA nor BZP increased aggression. As revealed in earlier research with adult rats, both drugs proved to be remarkably similar in their overall behavioral effects.
Export Options
About this article
Cite this article as:
Johnson N.L. Hamish and Hughes N. Robert, Acute Methamphetamine and Benzylpiperazine Decrease Aggression- Related Behavior in Late Adolescent Male Rats, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113020990003
DOI https://dx.doi.org/10.2174/22115560113020990003 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Modulation of Apoptosis in Acute Ischemic Stroke as Treatment Challenges
Current Immunology Reviews (Discontinued) Regulators of Chemokine Receptor Activity as Promising Anticancer Therapeutics
Current Cancer Drug Targets Preclinical Assessment of Drug Combinations for the Treatment of Pain: Isobolographic and Dose-Addition Analysis of the Opioidergic System
CNS & Neurological Disorders - Drug Targets Editorial - Advances of Alzheimers Disease Research: Crossroad of Basic and Translational Studies
Current Alzheimer Research Transformation of UPLC-MS Data Overcomes Extreme Variability in Urine Concentration and Metabolite Fold Change
Current Metabolomics Childhood and Adulthood Rural Residence Increases the Risk of Dementia: NEDICES Study
Current Alzheimer Research Stress Related Neuroendocrine Influences in Ovarian Cancer
Current Cancer Therapy Reviews GABA<sub>B</sub> Agonists for the Treatment of Alcohol Use Disorder
Current Pharmaceutical Design A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer’s Disease
Current Alzheimer Research Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Current Neuropharmacology The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Current Medicinal Chemistry B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity
Current Medicinal Chemistry The Potential Health Benefits of Algae and Micro Algae in Medicine: A Review on Spirulina platensis
Current Nutrition & Food Science Efficacy of Vitamins B Supplementation on Mild Cognitive Impairment and Alzheimer`s Disease: A Systematic Review and Meta-Analysis
Current Alzheimer Research Fenofibrate, Homocysteine and Renal Function
Current Vascular Pharmacology Nitric Oxide and Arginine Dysregulation: A Novel Pathway to Pulmonary Hypertension in Hemolytic Disorders
Current Molecular Medicine G-Protein Coupled Receptor Resensitization - Appreciating the Balancing Act of Receptor Function
Current Molecular Pharmacology Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor
Mini-Reviews in Medicinal Chemistry